Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Buys Two Shops to Bolster Maternal Health Play, Will Supply Screening Tools to Texas

NEW YORK (GenomeWeb News) – PerkinElmer has acquired NTD Laboratories and J.N. Macri Technologies for around $56.65 million, bringing the company closer to its goal of building a “screening and diagnostics capability in maternal health,” PerkinElmer said today.

Separately today, PerkinElmer said Texas has selected it to supply instruments and reagents for its enhanced newborn screening program.

J.N. Macri Technologies holds global patents related to free beta Human Chorionic Gonadotropin, a peptide hormone produced in the early stage of pregnancy that is “widely recognized as a critical biomarker for first-trimester prenatal risk assessment,” according to PerkinElmer.
NTD Laboratories, on the other hand, developed UltraScreen, a screening test that when used with ultrasound and maternal demographic data provides clinicians with a patient-specific risk probability for fetal abnormalities.
With these companies, PerkinElmer can develop screening and diagnostics capabilities in maternal health.
Meantime, under the multi-year agreement with Texas, PerkinElmer will supply the Texas Department of State Health Services Laboratory with tandem mass spectrometry systems, reagent kits, and software enhancements.
PerkinElmer has similar agreements with eight other states, including Alabama, California, Florida, Kentucky, Louisiana, Missouri, Pennsylvania and South Carolina.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.